On January 18, 2023 Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, reported that management will participate in the following investor conferences (Press release, Gritstone Oncology, JAN 18, 2023, View Source [SID1234626327]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

B. Riley Securities’ 3rd Annual Oncology Conference (Fireside Chat)
Date and Time: Thursday, January 19, 2023 at 12:30pm ET
Presenter: Andrew Allen, M.D., Ph.D., Co-founder, President, and Chief Executive Officer

2023 BIO CEO & Investor Conference (Panel)
Panel Title: Prioritizing CRO Spending Through a High-Inflation, Sparse-Funding Period
Date and Time: Monday, February 6, 2023 at 2:00pm ET
Presenter: Celia Economides, Chief Financial Officer

SVB Securities Global Biopharma Conference (Fireside Chat)
Date and Time: Thursday, February 16, 2023 at 1:40pm ET
Presenter: Andrew Allen, M.D., Ph.D., Co-founder, President, and Chief Executive Officer

Live webcast and/or archived replays will be available via View Source Archived replays will be accessible for at least 30 days following the corresponding event.